Evidence map›Paper›PMID 17283209›Full record

ArticleThe Journal of experimental medicine2007

Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection.

Dragana Jankovic, Marika C Kullberg, Carl G Feng, Romina S Goldszmid, Carmen M Collazo, Mark Wilson, Thomas A Wynn, Masahito Kamanaka, Richard A Flavell, Alan Sher

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of experimental medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 295 papers.

0numbers the graph read from it
0cells of the map it votes in
295citing papers in PubMed
41.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

295 citing papers in PubMed, 588 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. T-bet-expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. CXCR6bioRxiv : the preprint server for biology · 2025
    Article
  8. Possible link betweenAfrican health sciences · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Activation and Regulation of Indirect Alloresponses in Transplanted Patients With Donor Specific Antibodies and Chronic Rejection.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  15. Siglec-FTheranostics · 2024
    Article
  16. The role of CD4Frontiers in cellular and infection microbiology · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article

235 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Dragana JankovicImmunobiology Section and 2Immunopathogenesis Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. DJankovic@niaid.nih.gov
Marika C Kullberg
Carl G Feng
Romina S Goldszmid
Carmen M Collazo
Mark Wilson
Thomas A Wynn
Masahito Kamanaka
Richard A Flavell
Alan Sher
Institute of Neuroimmunology of the Slovak Academy of Sciences · SKYale University · USNational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

Approaches To Immunological Intervention In SchistosomiasisZIAAI000829 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI WYNN, THOMAS · 2009 to 2018
$9.9M
Immune Regulation In Toxoplasmosis And Other Opportunistic InfectionsZIAAI000579 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SHER, ALAN · 2009 to 2022
$7.8M
STUDIES ON IMMUNE REGULATION IN TOXOPLASMOSISZ01AI000579 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI SHER, ALAN · 1990 to 2008
$4.0M
Immunological Intervention In SchistosomiasisZ01AI000829 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI WYNN, THOMAS · 1998 to 2008
$3.4M
Intramural NIH HHS
6 · The paper itself

Abstract

Although interferon gamma (IFN-gamma) secretion is essential for control of most intracellular pathogens, host survival often also depends on the expression of interleukin 10 (IL-10), a cytokine known to counteract IFN-gamma effector functions. We analyzed the source of regulatory IL-10 in mice infected with the protozoan parasite Toxoplasma gondii. Unexpectedly, IFN-gamma-secreting T-bet(+)Foxp3(-) T helper type 1 (Th1) cells were found to be the major producers of IL-10 in these animals. Further analysis revealed that the same IL-10(+)IFN-gamma(gamma) population displayed potent effector function against the parasite while, paradoxically, also inducing profound suppression of IL-12 production by antigen-presenting cells. Although at any given time point only a fraction of the cells appeared to simultaneously produce IL-10 and IFN-gamma, IL-10 production could be stimulated in IL-10(-)IFN-gamma(+) cells by further activation in vitro. In addition, experiments with T. gondii-specific IL-10(+)IFN-gamma(+) CD4 clones revealed that although IFN-gamma expression is imprinted and triggered with similar kinetics regardless of the state of Th1 cell activation, IL-10 secretion is induced more rapidly from recently activated than from resting cells. These findings indicate that IL-10 production by CD4(+) T lymphocytes need not involve a distinct regulatory Th cell subset but can be generated in Th1 cells as part of the effector response to intracellular pathogens.

Indexed as

AnimalsAntibodies, MonoclonalCytokinesInterferon-gammaInterleukin-10MiceMice, Inbred BALB CMice, Inbred C57BLSignal TransductionTh1 CellsToxoplasmaToxoplasmosisAntibodies, MonoclonalCytokinesInterferon-gammaInterleukin-10

Identifiers

PMID17283209
PMCPMC2118735
OpenAlexW2136097155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.